A common vitamin may help calm gut inflammation in Crohn’s and colitis, reshaping how doctors approach treatment.

Your physical health can affect your mental well-being. Here's how a UC diagnosis specifically might impact your psyche, and ...

Conventional wisdom holds that nonsteroidal anti-inflammatory drugs (NSAIDs) can trigger disease flares in patients with ...

Are those shakes and steaks silently sabotaging your body? Experts share which types of protein help a sensitive stomach and which might make it worse.

AnaptysBio has spun off its biopharma pipeline into First Tracks Biotherapeutics, shifting to a royalty-focused, virtual ...

April 13 () - Spyre Therapeutics said on Monday its experimental drug demonstrated a significant reduction ‌in disease ...

By Siddhi Mahatole April 13 (Reuters) - Spyre Therapeutics said on Monday its experimental drug showed a significant reduction in disease activity when tested in patients with ulcerative colitis in a ...

Spyre Therapeutics’ monoclonal antibody hit the key goal of a phase 2 study in ulcerative colitis (UC), which the company has touted as proof it can best Takeda’s Entyvio. The mid-stage trial ...

A study looks into the affect of vitamin D supplementation on people with irritable bowel disease, gut health, and the immune ...

We are extremely pleased with the completion of this milestone for Emrosi™,” said Claude Maraoui, Co-Founder, President, and CEO of Journey Medical Corporation. “Our focus on delivering cost-effective ...

These results underscore that fenebrutinib has potential as a high-efficacy oral treatment for RMS. Its unique mode of action may offer a differentiated profile by targeting dual drivers of MS within ...

Filing acceptance based on Phase III ALLEGORY data for Gazyva showing a significant reduction in disease activity compared with placebo in people with systemic lupus erythematosus (SLE)If approved, ...